Andrew Craig

Andrew Craig

Auto-generated profile, based on publicly available information

Andrew Craig

Department of Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MSMark E. Snyder
Mark E. Snyder
KMKaveh Moghbeli
Kaveh Moghbeli
ABAnna Bondonese
Anna Bondonese
ACAndrew Craig
Andrew Craig
IPIulia Popescu
Iulia Popescu
JMJohn F. McDyer
John F. McDyer
Acute cellular rejection is common after lung transplantation and is associated with an increased risk of early chronic rejection. We present combined single-cell RNA and TCR sequencing on recipient-derived T cells obtained from the bronchoalveolar lavage of three lung transplant recipients with rejection and compare them with T cells obtained from the same patients after treatment of rejection with high-dose systemic glucocorticoids. At the time of rejection, we found an oligoclonal expansion of cytotoxic CD8+ T cells that all persisted as tissue resident memory T cells after successful treatment. Persisting CD8+ allograft-resident T cells have reduced gene expression for cytotoxic mediators after therapy with glucocorticoids but accumulate around airways. This clonal expansion is discordant with circulating T cell clonal expansion at the time of rejection, suggesting in situ expansion. We thus highlight the accumulation of cytotoxic, recipient-derived tissue resident memory T cells within the lung allograft that persist despite the administration of high-dose systemic glucocorticoids. The long-term clinical consequences of this persistence have yet to be characterized.

7 January 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
KMKaveh Moghbeli
Kaveh Moghbeli
MLMadeline A. Lipp
Madeline A. Lipp
Marta BuenoMarta Bueno
Marta Bueno
ACAndrew Craig
Andrew Craig
MRMichelle Rojas
Michelle Rojas
MSMark E. Snyder
Mark E. Snyder
Chronic lung allograft dysfunction (CLAD) substantially limits long-term survival following lung transplantation. To identify potential targets for CLAD prevention, T cells from explanted CLAD lungs and lung-draining lymph nodes, as well as diseased and nondiseased controls were isolated and single-cell RNA sequencing and TCR sequencing were performed. TCR sequencing revealed a clonally expanded population of CD8 + tissue-resident memory T cells (TRMs) with high cytotoxic potential, including upregulation of KLRK1 , encoding the co-receptor NKG2D. These cytotoxic CD8 + TRMs accumulated around the CLAD airways and had a 100-fold increase in clonal overlap with lung-draining lymph nodes when compared with non-CLAD lungs. Using a murine model of orthotopic lung transplantation, we confirmed that cytotoxic CD8 + TRM accumulation was due to chronic rejection and not transplantation alone. Furthermore, blocking NKG2D in vivo attenuated the airway remodeling following transplantation and diminished airway accumulation of CD8 + T cells. Our findings support NKG2D as a potential therapeutic target for CLAD, affecting cytotoxic CD8 + TRM accumulation.